Page last updated: 2024-08-17

levodopa and raclopride

levodopa has been researched along with raclopride in 50 studies

Research

Studies (50)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (2.00)	18.7374
1990's	19 (38.00)	18.2507
2000's	19 (38.00)	29.6817
2010's	11 (22.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K	1
Bannister, R; Brooks, DJ; Frackowiak, RS; Ibanez, V; Lees, AJ; Marsden, CD; Mathias, CJ; Playford, ED; Quinn, N; Sawle, GV	1
Breese, GR; Criswell, HE; Iorio, LC; McQuade, RD; Mueller, RA	1
Långström, B	1
Fowler, CJ; Magnusson, O; Mohringe, B; Ogren, SO; Wijkström, A	1
Antoni, G; Bergström, M; Bjurling, P; Jacobson, GB; Långström, B; Matsumura, K; Onoe, H; Takechi, H; Watanabe, Y; Westerberg, G	1
Calne, DB; Doudet, D; Hewitt, KA; Nugent, R; Olanow, W; Pate, BD; Perl, DP; Shinotoh, H; Snow, BJ	1
Brooks, DJ; Lammerstma, AA; Lees, AJ; Playford, ED; Sawle, GV; Turjanski, N; Weeks, R	1
Antonini, A; Beer, HF; Leenders, KL; Madeja, UD; Oertel, WH; Schwarz, J	1
Carta, A; Cozzolino, A; Di Chiara, G; Fenu, S; Morelli, M; Pinna, A	1
Ahier, RG; Ashworth, S; Brooks, DJ; Hume, SP; Lammertsma, AA; Myers, R; Opacka-Juffry, J	1
Aquilonius, SM; Hartvig, P; Jacobsson, G; Långström, B; Pedersen, M; Tedroff, J	1
Biggs, C; Fowler, L; Starr, M; Whitton, P	1
Antonini, A; Leenders, KL; Oertel, WH; Pogarell, O; Schwarz, J	1
Derbiszewska, T; Nowak, JZ; Zawilska, JB	1
Andrén, PE; Ekesbo, A; Gunne, LM; Tedroff, J	1
Bjurling, P; Fasth, KJ; Hartvig, P; Långström, B; Tedroff, J; Torstenson, R; Watanabe, Y	1
Brooks, DJ; Lees, AJ; Turjanski, N	1
Calne, DB; de la Fuente-Fernandez, R; Kishore, A; Mak, E; Naini, AB; Nygaard, TG; Ruth, TJ; Schulzer, M; Snow, BJ; Stoessl, AJ	1
Ahier, RG; Ashworth, S; Hume, SP; Opacka-Juffry, J	1
Brousolle, E; Dentresangle, C; Froment, JC; Guerin, J; Lavenne, F; Le Bars, D; Pierre, C; Pollak, P; Veyre, L	1
Stoessl, AJ; Van Kampen, JM	1
Fukumoto, D; Harada, N; Kakiuchi, T; Nishiyama, S; Ohba, H; Sato, K; Tsukada, H	1
Andren, PE; Gunne, L; Svenningsson, P	1
Carpinelli, A; Comi, G; Fazio, F; Gobbo, C; Messa, C; Moresco, RM; Rizzo, G; Volonté, MA	1
Albani, F; Baruzzi, A; Contin, M; Martinelli, P; Riva, R	1
Fukumoto, D; Harada, N; Kakiuchi, T; Nishiyama, S; Satoh, K; Tsukada, H	1
Calne, DB; De La Fuente-Fernández, R; Furtado, S; Furukawa, Y; Guttman, M; Lee, CS; Ruth, TJ; Stoessl, AJ	1
Asbrock, N; Ferrer, B; Giuffrida, A; Kathuria, S; Piomelli, D	1
Fukumoto, D; Harada, N; Kakiuchi, T; Nishiyama, S; Tsukada, H	1
Fukumoto, D; Harada, N; Kakiuchi, T; Miyasato, K; Nishiyama, S; Tsukada, H	1
Hayashi, K; Honda, H; Kaneko, K; Kira, J; Koga, H; Kuwabara, Y; Nakagawa, M; Sasaki, M; Taniwaki, T	1
Eltayb, A; Svensson, TH; Wadenberg, ML	1
Ando, T; Itoh, M; Nakagawa, A; Nimura, T; Oikawa, T; Shibuya, S; Shirane, R; Tominaga, T; Yamaguchi, K	1
Appel, S; Brooks, DJ; Doder, M; Evans, AH; Lawrence, AD; Lees, AJ; Pavese, N; Piccini, P; Tai, YF	1
Breitenstein, C; Cohen, LG; Floel, A; Garraux, G; Herscovitch, P; Knecht, S; Xu, B	1
Brooks, DJ; Evans, AH; Hotton, G; Lees, AJ; Pavese, N; Piccini, P; Tai, YF	1
Iida, A; Inoue, N; Kakiuchi, T; Kondo, Y; Muramatsu, S; Nakano, I; Nakayama, T; Okuno, T; Ono, F; Suzuki, Y; Takino, N; Terao, K; Tsukada, H	1
Brennum, LT; Kirchhoff, J; Mørk, A; Sager, TN	1
Arakawa, R; Ito, H; Kodaka, F; Miyoshi, M; Okumura, M; Otsuka, T; Suhara, T; Takahashi, H; Takano, H	1
de la Fuente-Fernández, R; Dinelle, K; Lidstone, SC; Mak, E; Phillips, AG; Ruth, TJ; Schulzer, M; Sossi, V; Stoessl, AJ	1
Hamann, M; Lange, N; Richter, A; Shashidharan, P	1
Brantley, E; Karain, B; Shi, WX; Xu, D	1
Bido, S; Cenci, MA; Marti, M; Mela, F; Morari, M	1
Alstrup, AK; Doudet, DJ; Gjedde, A; Høltzermann, M; Jakobsen, S; Landau, AM; Møller, A; Nahimi, A; Simonsen, M; Vang, K; Wegener, G	1
Arakawa, R; Ito, H; Kodaka, F; Nogami, T; Suhara, T; Suzuki, M; Takahashi, H; Takahata, K; Takano, H	1
Bain, P; Brooks, DJ; Kiferle, L; Loane, C; Molloy, S; Piccini, P; Politis, M; Turkheimer, FE; Wu, K	1
Deserno, L; Holl, AK; Horstmann, A; Jahanshahi, M; Mathar, D; Neumann, J; Villringer, A; Wilkinson, L	1
Abi-Dargham, A; Bailey, V; Brown, PJ; Chen, C; Roose, SP; Rutherford, BR; Slifstein, M; Stern, Y; Valente, E; Vanegas-Arroyave, N; Wall, MW	1
Fridman, EA; Mozley, PD; Osborne, JR; Schiff, ND; Victor, JD	1

Reviews

1 review(s) available for levodopa and raclopride

Article	Year
Design of molecules labeled with beta+ emitters for use in multitracer investigations using positron emission tomography. Acta radiologica. Supplementum, 1990, Volume: 374 Topics: Beta Particles; Humans; Isotope Labeling; Levodopa; Methionine; Neurotransmitter Agents; Nomifensine; Raclopride; Salicylamides; Spiperone; Tomography, Emission-Computed	1990

Trials

5 trial(s) available for levodopa and raclopride

Article	Year
PET evaluation of the relationship between D2 receptor binding and glucose metabolism in patients with parkinsonism. Annals of nuclear medicine, 2005, Volume: 19, Issue:4 Topics: Adult; Aged; Antiparkinson Agents; Brain; Female; Fluorodeoxyglucose F18; Glucose; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Raclopride; Radiopharmaceuticals; Receptors, Dopamine D2; Tissue Distribution	2005
Levodopa increases memory encoding and dopamine release in the striatum in the elderly. Neurobiology of aging, 2008, Volume: 29, Issue:2 Topics: Aged; Attention; Biomechanical Phenomena; Blood Pressure; Corpus Striatum; Cross-Over Studies; Dopamine; Dopamine Agents; Dopamine Antagonists; Double-Blind Method; Female; Heart Rate; Humans; Levodopa; Male; Memory; Motor Skills; Positron-Emission Tomography; Raclopride; Teaching	2008
Serotonergic mechanisms responsible for levodopa-induced dyskinesias in Parkinson's disease patients. The Journal of clinical investigation, 2014, Volume: 124, Issue:3 Topics: Aged; Antiparkinson Agents; Buspirone; Case-Control Studies; Dopamine; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Putamen; Raclopride; Radionuclide Imaging; Radiopharmaceuticals; Serotonergic Neurons; Serotonin 5-HT1 Receptor Agonists; Synapses; Treatment Outcome	2014
Effects of L-DOPA Monotherapy on Psychomotor Speed and [ Biological psychiatry, 2019, 08-01, Volume: 86, Issue:3 Topics: Aged; Aged, 80 and over; Carbidopa; Corpus Striatum; Depressive Disorder, Major; Dopamine; Dopamine Antagonists; Drug Combinations; Female; Humans; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; New York; Positron-Emission Tomography; Raclopride; Receptors, Dopamine D2; Walking Speed	2019
Presynaptic dopamine deficit in minimally conscious state patients following traumatic brain injury. Brain : a journal of neurology, 2019, 07-01, Volume: 142, Issue:7 Topics: Adult; Brain Injuries, Traumatic; Corpus Striatum; Dextroamphetamine; Dopamine; Dopamine Plasma Membrane Transport Proteins; Female; Humans; Levodopa; Male; Persistent Vegetative State; Positron-Emission Tomography; Presynaptic Terminals; Raclopride; Receptors, Dopamine D2; Substantia Nigra; Tegmentum Mesencephali; Thalamus; Young Adult	2019

Other Studies

44 other study(ies) available for levodopa and raclopride

Article	Year
QSAR-based permeability model for drug-like compounds. Bioorganic & medicinal chemistry, 2011, Apr-15, Volume: 19, Issue:8 Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship	2011
Striatal D2 receptor status in patients with Parkinson's disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11C-raclopride and positron emission tomography. Annals of neurology, 1992, Volume: 31, Issue:2 Topics: Adult; Aged; Caudate Nucleus; Corpus Striatum; Humans; Levodopa; Middle Aged; Nerve Degeneration; Parkinson Disease; Putamen; Raclopride; Receptors, Dopamine; Salicylamides; Substantia Nigra; Supranuclear Palsy, Progressive; Tomography, Emission-Computed	1992
Pharmacological evaluation of SCH-12679: evidence for an in vivo antagonism of D1-dopamine receptors. The Journal of pharmacology and experimental therapeutics, 1990, Volume: 252, Issue:2 Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Aggression; Animals; Antipsychotic Agents; Avoidance Learning; Benzazepines; Dopamine Antagonists; Female; Hydroxydopamines; Levodopa; Oxidopamine; Pregnancy; Raclopride; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Salicylamides	1990
Comparison of the effects of haloperidol, remoxipride and raclopride on "pre"- and postsynaptic dopamine receptors in the rat brain. Naunyn-Schmiedeberg's archives of pharmacology, 1988, Volume: 337, Issue:4 Topics: Adrenergic alpha-Agonists; Animals; Antipsychotic Agents; Azepines; Behavior, Animal; Benzamides; Brain; Haloperidol; Levodopa; Male; Raclopride; Rats; Rats, Inbred Strains; Receptors, Dopamine; Remoxipride; Salicylamides	1988
In vitro positron emission tomography (PET): use of positron emission tracers in functional imaging in living brain slices. Neuroscience research, 1995, Volume: 22, Issue:2 Topics: Animals; Brain; Buffers; Carbon Radioisotopes; Culture Media; Deoxyglucose; Dopamine; Dopamine Antagonists; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Kinetics; Levodopa; Male; Neurotransmitter Agents; Organ Culture Techniques; Protein Binding; Raclopride; Rats; Rats, Sprague-Dawley; Salicylamides; Tomography, Emission-Computed	1995
MRI and PET studies of manganese-intoxicated monkeys. Neurology, 1995, Volume: 45, Issue:6 Topics: Animals; Carbidopa; Corpus Striatum; Deoxyglucose; Drug Therapy, Combination; Dystonia; Fluorodeoxyglucose F18; Globus Pallidus; Glucose; Levodopa; Macaca mulatta; Magnetic Resonance Imaging; Male; Manganese Poisoning; Parkinson Disease, Secondary; Raclopride; Salicylamides; Substantia Nigra; Tomography, Emission-Computed	1995
PET studies of the presynaptic and postsynaptic dopaminergic system in Tourette's syndrome. Journal of neurology, neurosurgery, and psychiatry, 1994, Volume: 57, Issue:6 Topics: Adolescent; Adult; Antipsychotic Agents; Carbon Radioisotopes; Case-Control Studies; Caudate Nucleus; Dihydroxyphenylalanine; Dopamine D2 Receptor Antagonists; Female; Fluorine Radioisotopes; Humans; Levodopa; Male; Matched-Pair Analysis; Middle Aged; Presynaptic Terminals; Putamen; Raclopride; Receptors, Dopamine; Salicylamides; Tomography, Emission-Computed; Tourette Syndrome	1994
[11C]raclopride and positron emission tomography in previously untreated patients with Parkinson's disease: Influence of L-dopa and lisuride therapy on striatal dopamine D2-receptors. Neurology, 1994, Volume: 44, Issue:7 Topics: Adult; Aged; Animals; Carbon Radioisotopes; Corpus Striatum; Dopamine D2 Receptor Antagonists; Female; Humans; Levodopa; Lisuride; Macaca mulatta; Male; Middle Aged; Parkinson Disease; Raclopride; Receptors, Dopamine D2; Salicylamides; Tomography, Emission-Computed	1994
L-dopa stimulates c-fos expression in dopamine denervated striatum by combined activation of D-1 and D-2 receptors. Brain research, 1993, Oct-01, Volume: 623, Issue:2 Topics: Animals; Benzazepines; Corpus Striatum; Denervation; Dopamine; Dopamine D2 Receptor Antagonists; Levodopa; Male; Proto-Oncogene Proteins c-fos; Raclopride; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Salicylamides	1993
Effect of L-dopa and 6-hydroxydopamine lesioning on [11C]raclopride binding in rat striatum, quantified using PET. Synapse (New York, N.Y.), 1995, Volume: 21, Issue:1 Topics: Animals; Binding, Competitive; Corpus Striatum; Dopamine Antagonists; Dose-Response Relationship, Drug; Levodopa; Male; Microdialysis; Oxidopamine; Raclopride; Rats; Rats, Sprague-Dawley; Salicylamides; Time Factors	1995
Levodopa-induced changes in synaptic dopamine in patients with Parkinson's disease as measured by [11C]raclopride displacement and PET. Neurology, 1996, Volume: 46, Issue:5 Topics: Aged; Antiparkinson Agents; Carbon Radioisotopes; Caudate Nucleus; Corpus Striatum; Dopamine; Dopamine Antagonists; Female; Functional Laterality; Humans; Levodopa; Male; Middle Aged; Motor Activity; Parkinson Disease; Putamen; Raclopride; Salicylamides; Synapses; Tomography, Emission-Computed	1996
Effects of glutamate antagonists on nigral dopamine release in the reserpine-treated rat. Biochemical Society transactions, 1996, Volume: 24, Issue:1 Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; alpha-Methyltyrosine; Animals; Dizocilpine Maleate; Dopamine; Dopamine Agonists; Dopamine Antagonists; Excitatory Amino Acid Antagonists; Glutamic Acid; Levodopa; Methyltyrosines; Raclopride; Rats; Reserpine; Salicylamides; Substantia Nigra	1996
Long-term changes of striatal dopamine D2 receptors in patients with Parkinson's disease: a study with positron emission tomography and [11C]raclopride. Movement disorders : official journal of the Movement Disorder Society, 1997, Volume: 12, Issue:1 Topics: Aged; Antiparkinson Agents; Caudate Nucleus; Corpus Striatum; Dopamine Agonists; Dopamine Antagonists; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Levodopa; Longitudinal Studies; Male; Middle Aged; Neural Pathways; Parkinson Disease; Putamen; Raclopride; Receptors, Dopamine D2; Salicylamides; Substantia Nigra; Tomography, Emission-Computed	1997
Pharmacological modifications in dopaminergic neurotransmission affect the quinpirole-evoked suppression of serotonin N-acetyltransferase activity in chick retina: an impact on dopamine D4-like receptors. Journal of neural transmission (Vienna, Austria : 1996), 1996, Volume: 103, Issue:12 Topics: Animals; Antipsychotic Agents; Arylamine N-Acetyltransferase; Chickens; Circadian Rhythm; Clozapine; Dopamine Agents; Enzyme Inhibitors; Levodopa; Male; Quinpirole; Raclopride; Receptors, Dopamine D2; Receptors, Dopamine D4; Retina; Salicylamides; Sulpiride; Synaptic Transmission	1996
(-)-OSU 6162 inhibits levodopa-induced dyskinesias in a monkey model of Parkinson's disease. Neuroreport, 1997, Jul-28, Volume: 8, Issue:11 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Callithrix; Carbidopa; Dopamine Antagonists; Levodopa; Male; Motor Activity; Parkinson Disease, Secondary; Piperidines; Posture; Raclopride; Salicylamides	1997
Amphetamine effects on dopamine release and synthesis rate studied in the Rhesus monkey brain by positron emission tomography. Journal of neural transmission (Vienna, Austria : 1996), 1997, Volume: 104, Issue:4-5 Topics: Amphetamine; Animals; Brain; Cerebrovascular Circulation; Decarboxylation; Dopamine; Dopamine Agents; Dopamine Agonists; Dopamine Antagonists; Female; Levodopa; Macaca mulatta; Raclopride; Salicylamides; Spiperone; Tomography, Emission-Computed	1997
In vivo studies on striatal dopamine D1 and D2 site binding in L-dopa-treated Parkinson's disease patients with and without dyskinesias. Neurology, 1997, Volume: 49, Issue:3 Topics: Adult; Aged; Carbon Radioisotopes; Corpus Striatum; Female; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease; Raclopride; Receptors, Dopamine D1; Receptors, Dopamine D2; Salicylamides	1997
Striatal D2 receptors in symptomatic and asymptomatic carriers of dopa-responsive dystonia measured with [11C]-raclopride and positron-emission tomography. Neurology, 1998, Volume: 50, Issue:4 Topics: Adult; Age Factors; Age of Onset; Biopterins; Carbon Radioisotopes; Corpus Striatum; Dopamine Agents; Dopamine Antagonists; Dystonia; Female; Heterozygote; Humans; Levodopa; Male; Middle Aged; Raclopride; Receptors, Dopamine D2; Salicylamides; Sex Factors; Synaptic Membranes; Tomography, Emission-Computed	1998
Modulatory effects of L-DOPA on D2 dopamine receptors in rat striatum, measured using in vivo microdialysis and PET. Journal of neural transmission (Vienna, Austria : 1996), 1998, Volume: 105, Issue:4-5 Topics: Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Carbidopa; Carbon Radioisotopes; Corpus Striatum; Dopamine; Enzyme Inhibitors; gamma-Aminobutyric Acid; Globus Pallidus; Hydrazines; Kinetics; Levodopa; Male; Microdialysis; Raclopride; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Salicylamides; Time Factors; Tomography, Emission-Computed	1998
Striatal D2 dopamine receptor status in Parkinson's disease: an [18F]dopa and [11C]raclopride PET study. Movement disorders : official journal of the Movement Disorder Society, 1999, Volume: 14, Issue:6 Topics: Adult; Aged; Antiparkinson Agents; Brain Mapping; Carbidopa; Carbon Radioisotopes; Corpus Striatum; Dihydroxyphenylalanine; Drug Combinations; Female; Fluorine Radioisotopes; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Raclopride; Receptors, Dopamine D2; Tomography, Emission-Computed	1999
Effects of oligonucleotide antisense to dopamine D(1A) receptor messenger RNA in a rodent model of levodopa-induced dyskinesia. Neuroscience, 2000, Volume: 98, Issue:1 Topics: Animals; Antiparkinson Agents; Apomorphine; Autoradiography; Behavior, Animal; Cocaine; Denervation; Disease Models, Animal; Dopamine Antagonists; Dopamine Uptake Inhibitors; Dyskinesia, Drug-Induced; Gene Expression; Levodopa; Male; Oligonucleotides, Antisense; Oxidopamine; Phenotype; Raclopride; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; RNA, Messenger; Rotation; Substantia Nigra; Sympatholytics; Tritium	2000
Ketamine decreased striatal [(11)C]raclopride binding with no alterations in static dopamine concentrations in the striatal extracellular fluid in the monkey brain: multiparametric PET studies combined with microdialysis analysis. Synapse (New York, N.Y.), 2000, Volume: 37, Issue:2 Topics: Animals; Brain; Carbon Radioisotopes; Carrier Proteins; Cocaine; Corpus Striatum; Dopamine; Dopamine Agents; Dopamine Antagonists; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Extracellular Space; Ketamine; Levodopa; Macaca mulatta; Magnetic Resonance Imaging; Male; Membrane Glycoproteins; Membrane Transport Proteins; Microdialysis; Nerve Tissue Proteins; Osmolar Concentration; Raclopride; Tomography, Emission-Computed	2000
L-DOPA produces strong induction of c-fos messenger RNA in dopamine-denervated cortical and striatal areas of the common marmoset. Neuroscience, 2000, Volume: 99, Issue:3 Topics: Animals; Benzazepines; Blotting, Western; Callithrix; Cerebral Cortex; Corpus Striatum; Denervation; Disease Models, Animal; Dopamine; Dopamine Agents; Dopamine Antagonists; Enkephalins; Gene Expression; Genes, Immediate-Early; Levodopa; Nerve Degeneration; Oxidopamine; Parkinson Disease; Protein Precursors; Proto-Oncogene Proteins c-fos; Raclopride; Radioligand Assay; Receptors, Dopamine D1; Receptors, Dopamine D2; RNA, Messenger; Substance P; Substantia Nigra; Sympatholytics; Tritium	2000
A PET study with [11-C]raclopride in Parkinson's disease: preliminary results on the effect of amantadine on the dopaminergic system. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2001, Volume: 22, Issue:1 Topics: Aged; Amantadine; Binding, Competitive; Carbon Radioisotopes; Dopamine; Dopamine Agents; Dopamine Antagonists; Drug Interactions; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Presynaptic Terminals; Putamen; Raclopride; Radioligand Assay; Receptors, Dopamine D2; Tomography, Emission-Computed	2001
Pharmacodynamic modeling of oral levodopa in Parkinson's disease. Annals of neurology, 2001, Volume: 50, Issue:5 Topics: Disease Progression; Dose-Response Relationship, Drug; Humans; Levodopa; Parkinson Disease; Predictive Value of Tests; Psychomotor Performance; Raclopride; Tomography, Emission-Computed	2001
Age-related changes in the striatal dopaminergic system in the living brain: a multiparametric PET study in conscious monkeys. Synapse (New York, N.Y.), 2002, Volume: 45, Issue:1 Topics: Aging; Animals; Benzazepines; Cocaine; Corpus Striatum; Dopamine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Extracellular Space; Levodopa; Macaca mulatta; Magnetic Resonance Imaging; Male; Microdialysis; Piperazines; Raclopride; Tomography, Emission-Computed	2002
VMAT2 binding is elevated in dopa-responsive dystonia: visualizing empty vesicles by PET. Synapse (New York, N.Y.), 2003, Volume: 49, Issue:1 Topics: Adolescent; Adult; Carbon Radioisotopes; Corpus Striatum; Cytoplasmic Vesicles; Dopamine; Dopamine Agents; Dystonic Disorders; Female; Fluorine Radioisotopes; Humans; Levodopa; Male; Membrane Glycoproteins; Membrane Transport Proteins; Methylphenidate; Middle Aged; Neuropeptides; Parkinson Disease; Raclopride; Tetrabenazine; Tomography, Emission-Computed; Vesicular Biogenic Amine Transport Proteins; Vesicular Monoamine Transport Proteins	2003
Effects of levodopa on endocannabinoid levels in rat basal ganglia: implications for the treatment of levodopa-induced dyskinesias. The European journal of neuroscience, 2003, Volume: 18, Issue:6 Topics: Animals; Antiparkinson Agents; Basal Ganglia; Behavior, Animal; Benzazepines; Benzoxazines; Brain Chemistry; Cannabinoid Receptor Modulators; Chromatography, High Pressure Liquid; Disease Models, Animal; Dopamine Antagonists; Drug Interactions; Dyskinesia, Drug-Induced; Dyskinesias; Endocannabinoids; Gas Chromatography-Mass Spectrometry; Levodopa; Male; Morpholines; Mouth; Naphthalenes; Oxidopamine; Parkinson Disease; Piperidines; Pyrazoles; Raclopride; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Rimonabant; Substantia Nigra; Time Factors	2003
Acute NMDA receptor antagonism induces biphasic striatal utilization of L-[beta-11C]DOPA: PET studies in the conscious monkey brain. Synapse (New York, N.Y.), 2005, Volume: 57, Issue:2 Topics: Animals; Binding, Competitive; Carbon Radioisotopes; Cocaine; Consciousness; Corpus Striatum; Dopamine; Excitatory Amino Acid Antagonists; Glutamic Acid; Levodopa; Macaca mulatta; Male; Neural Pathways; Positron-Emission Tomography; Presynaptic Terminals; Raclopride; Receptors, Dopamine D2; Receptors, N-Methyl-D-Aspartate; Synaptic Transmission	2005
Nicotine modulates dopamine synthesis rate as determined by L-[beta-11C]DOPA: PET studies compared with [11C]raclopride binding in the conscious monkey brain. Synapse (New York, N.Y.), 2005, Volume: 57, Issue:2 Topics: Acetylcholine; Animals; Binding, Competitive; Brain; Carbon Radioisotopes; Cerebellum; Consciousness; Corpus Striatum; Dizocilpine Maleate; Dopamine; Dopamine Antagonists; Excitatory Amino Acid Antagonists; Levodopa; Macaca mulatta; Male; Neural Pathways; Nicotine; Positron-Emission Tomography; Presynaptic Terminals; Raclopride; Synaptic Transmission	2005
Enhanced cortical dopamine output and antipsychotic-like effect of raclopride with adjunctive low-dose L-dopa. Biological psychiatry, 2005, Aug-15, Volume: 58, Issue:4 Topics: Analysis of Variance; Animals; Avoidance Learning; Benserazide; Catalepsy; Dopamine; Dopamine Agents; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Combinations; Drug Interactions; Enzyme Inhibitors; Levodopa; Male; Microdialysis; Nucleus Accumbens; Prefrontal Cortex; Raclopride; Rats; Rats, Wistar; Time Factors	2005
Attenuation of fluctuating striatal synaptic dopamine levels in patients with Parkinson disease in response to subthalamic nucleus stimulation: a positron emission tomography study. Journal of neurosurgery, 2005, Volume: 103, Issue:6 Topics: Aged; Caudate Nucleus; Corpus Striatum; Deep Brain Stimulation; Dopamine; Dopamine Agents; Dopamine Antagonists; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Putamen; Raclopride; Severity of Illness Index; Stereotaxic Techniques; Subthalamic Nucleus; Treatment Outcome	2005
Compulsive drug use linked to sensitized ventral striatal dopamine transmission. Annals of neurology, 2006, Volume: 59, Issue:5 Topics: Aged; Brain Mapping; Dopamine; Dopamine Agents; Dopamine Antagonists; Exploratory Behavior; Female; Humans; Levodopa; Male; Middle Aged; Neostriatum; Positron-Emission Tomography; Psychological Tests; Raclopride; Receptors, Dopamine D2; Receptors, Dopamine D3; Substance-Related Disorders; Synaptic Transmission	2006
Clinical correlates of levodopa-induced dopamine release in Parkinson disease: a PET study. Neurology, 2006, Nov-14, Volume: 67, Issue:9 Topics: Administration, Oral; Carbon Radioisotopes; Corpus Striatum; Disability Evaluation; Dopamine; Dopamine Agents; Dopamine Antagonists; Drug Administration Schedule; Female; Humans; Levodopa; Male; Parkinson Disease; Positron-Emission Tomography; Presynaptic Terminals; Raclopride; Synaptic Transmission; Treatment Outcome	2006
Multitracer assessment of dopamine function after transplantation of embryonic stem cell-derived neural stem cells in a primate model of Parkinson's disease. Synapse (New York, N.Y.), 2009, Volume: 63, Issue:7 Topics: Animals; Carbon Radioisotopes; Cells, Cultured; Cocaine; Disease Models, Animal; Dopamine; Dopamine Agents; Embryonic Stem Cells; Levodopa; Macaca fascicularis; Methamphetamine; Movement Disorders; Neurons; Parkinson Disease; Positron-Emission Tomography; Putamen; Raclopride; Tyrosine 3-Monooxygenase	2009
Striatal extracellular dopamine levels and behavioural reversal in MPTP-lesioned mice. Neuroreport, 2009, Mar-25, Volume: 20, Issue:5 Topics: Animals; Behavior, Animal; Corpus Striatum; Dopamine; Dopamine Agents; Extracellular Space; Levodopa; Male; Mice; Mice, Inbred C57BL; Motor Activity; MPTP Poisoning; Neurotoxins; Raclopride; Receptors, Dopamine D2; Tritium	2009
Effects of the antipsychotic risperidone on dopamine synthesis in human brain measured by positron emission tomography with L-[beta-11C]DOPA: a stabilizing effect for dopaminergic neurotransmission? The Journal of neuroscience : the official journal of the Society for Neuroscience, 2009, Oct-28, Volume: 29, Issue:43 Topics: Adult; Antipsychotic Agents; Brain; Carbon Radioisotopes; Caudate Nucleus; Dopamine; Dose-Response Relationship, Drug; Humans; Isoxazoles; Levodopa; Male; Paliperidone Palmitate; Positron-Emission Tomography; Putamen; Pyrimidines; Raclopride; Receptors, Dopamine D2; Rest; Risperidone; Synaptic Transmission; Young Adult	2009
Effects of expectation on placebo-induced dopamine release in Parkinson disease. Archives of general psychiatry, 2010, Volume: 67, Issue:8 Topics: Aged; Antiparkinson Agents; Attitude to Health; Basal Ganglia; British Columbia; Clinical Trials as Topic; Dopamine; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Placebo Effect; Placebos; Positron-Emission Tomography; Raclopride; Research Design; Reward	2010
Behavioural and pharmacological examinations in a transgenic mouse model of early-onset torsion dystonia. Pharmacology, biochemistry, and behavior, 2011, Volume: 97, Issue:4 Topics: Amphetamines; Animals; Anxiety; Behavior, Animal; Carbidopa; Chromans; Disease Models, Animal; Dystonia; Levodopa; Locomotion; Mice; Mice, Transgenic; Quinpirole; Raclopride	2011
Effects of L-DOPA on nigral dopamine neurons and local field potential: comparison with apomorphine and muscimol. The Journal of pharmacology and experimental therapeutics, 2011, Volume: 337, Issue:2 Topics: Animals; Apomorphine; Dopamine; Dopamine Agents; Dopamine Agonists; Dopamine Antagonists; Electrophysiological Phenomena; Evoked Potentials; GABA Agonists; Levodopa; Male; Muscimol; Neurons; Parkinson Disease, Secondary; Raclopride; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Substantia Nigra	2011
In vivo evidence for a differential contribution of striatal and nigral D1 and D2 receptors to L-DOPA induced dyskinesia and the accompanying surge of nigral amino acid levels. Neurobiology of disease, 2012, Volume: 45, Issue:1 Topics: Animals; Benzazepines; Corpus Striatum; Dopamine Antagonists; Dyskinesia, Drug-Induced; gamma-Aminobutyric Acid; Glutamic Acid; Levodopa; Male; Microdialysis; Raclopride; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Substantia Nigra	2012
Serotonergic modulation of receptor occupancy in rats treated with L-DOPA after unilateral 6-OHDA lesioning. Journal of neurochemistry, 2012, Volume: 120, Issue:5 Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Analysis of Variance; Animals; Antiparkinson Agents; Autoradiography; Carbon Isotopes; Cocaine; Disease Models, Animal; Dopamine; Dopamine Uptake Inhibitors; Dyskinesia, Drug-Induced; Female; Functional Laterality; Levodopa; Microdialysis; Motor Activity; Oxidopamine; Parkinson Disease; Positron-Emission Tomography; Protein Binding; Raclopride; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Receptors, Serotonin; Serotonergic Neurons; Serotonin Receptor Agonists	2012
Effects of dopamine D2 receptor partial agonist antipsychotic aripiprazole on dopamine synthesis in human brain measured by PET with L-[β-11C]DOPA. PloS one, 2012, Volume: 7, Issue:9 Topics: Adult; Antipsychotic Agents; Aripiprazole; Binding, Competitive; Carbon Radioisotopes; Caudate Nucleus; Dopamine; Dopamine D2 Receptor Antagonists; Humans; Levodopa; Male; Neuroimaging; Piperazines; Positron-Emission Tomography; Putamen; Quinolones; Raclopride; Radiopharmaceuticals; Receptors, Dopamine D2; Tissue Distribution; Young Adult	2012
The role of dopamine in positive and negative prediction error utilization during incidental learning - Insights from Positron Emission Tomography, Parkinson's disease and Huntington's disease. Cortex; a journal devoted to the study of the nervous system and behavior, 2017, Volume: 90 Topics: Aged; Dopamine; Female; Humans; Huntington Disease; Learning; Levodopa; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Raclopride; Reinforcement, Psychology; Ventral Striatum	2017